Medicaid

Expanding Access to Food as Medicine

Expanding Access to Food as Medicine

Policymakers debate whether to use federal health care funding to cover nutrition programs.

Immigrant Eligibility for Federal Benefits Programs

Immigrant Eligibility for Federal Benefits Programs

Scholars explore how barriers to public benefits impact noncitizens’ well-being.

Examining Health Care Equities

Examining Health Care Equities

Allison K. Hoffman discusses the role of state ballot initiatives, federal law, and private equity in the U.S. health care system.

The Bounded Triumph of Health Care Ballot Initiatives

The Bounded Triumph of Health Care Ballot Initiatives

Medicaid expansion ballot initiatives show state referenda can expand health care access—but they have their limits.

Medical Debt Collection

Medical Debt Collection

Experts discuss how regulators can protect consumers from aggressive collection practices.

States Renew Push for Medicaid Work Requirements

States Renew Push for Medicaid Work Requirements

Scholars evaluate the impact of work requirements on Medicaid beneficiaries.

The Troubled Teen Industry’s Troubling Lack of Oversight

The Troubled Teen Industry’s Troubling Lack of Oversight

The federal government must step in to regulate an industry fraught with youth abuse.

Negotiating Prices with Drug Manufacturers

Negotiating Prices with Drug Manufacturers

The Inflation Reduction Act aims to constrain rapidly increasing drug prices in the United States.

Long-Term Care at Home

Long-Term Care at Home

Experts discuss how to improve home and community-based services.

Crisis Pregnancy Centers, State-Funded Harm, and State-Based Solutions

Crisis Pregnancy Centers, State-Funded Harm, and State-Based Solutions

As the Supreme Court evaluates abortion laws, states should bolster reproductive rights and better regulate CPCs.

Experimenting with Medicaid

Experimenting with Medicaid

Scholars explore how Section 1115 waivers can expand or reduce health coverage.

Regulating Drugs at a Discount

Regulating Drugs at a Discount

Scholars examine the effectiveness of the contentious 340B Drug Pricing Program.